Skip to main content
. 2003 Jul 15;89(2):246–247. doi: 10.1038/sj.bjc.6601116

Figure 1.

Figure 1

Case 4: Brain CT-scan at baseline (A) and after 3 months of ZD1839 therapy (B). Brain metastasis from NSCLC responding to ZD 1839 therapy. This patient has been pretreated with three lines of chemotherapy including platinum and taxanes, and received ZD 1839 after whole-brain radiotherapy failure.